TrialGynecologic oncology2016

A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study.

Elizabeth R Burton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.